Artelo biosciences ceo to participate in the benzinga all access event on july 11

Solana beach, calif., july 10, 2023 (globe newswire) -- artelo biosciences, inc.  (nasdaq: artl), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that gregory d. gorgas, president & chief executive officer of artelo biosciences, will be participating in the benzinga all access event taking place on tuesday, july 11, 2023.
ARTL Ratings Summary
ARTL Quant Ranking